Fidelity US Value ETF【FCUV】銘柄情報 | ADVFN

US Dollar vs Yen

登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

登録

ホーム
投資
ETF
カナダ
TSX
Fidelity US Value ETF (FCUV) 銘柄情報

Fidelity US Value ETF (FCUV)

20.02

-0.01

( -0.05% )

更新日時： 00:08:21

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

20.02

買値

20.02

売値

20.04

出来高

5,624

20.02 日の範囲 20.10

0.00 52 週間の範囲 0.00

時価総額

前日終値

20.03

始値

20.08

時刻

最終取引時間

00:00:56

財務取引量

-

VWAP

-

平均取引量 (3 か月)

-

発行済株式数

21,900,000

配当利回り

-

PER

5.68

1 株当たり利益 (EPS)

3.53

歳入

78.78M

純利益

77.26M

セクター

Finance Services

業界

Finance Services

本社

Toronto, Ontario, Can

設立

-

Fidelity US Value ETF is listed in the Finance Services sector of the トロント証券取引所 with ticker FCUV. The last closing price for Fidelity US Value ETF was $20.03. Over the last year, Fidelity US Value ETF shares have traded in a share price range of $ 0.00 to $ 0.00.

Fidelity US Value ETF currently has 21,900,000 shares in issue. The market capitalisation of Fidelity US Value ETF is $438.66 million. Fidelity US Value ETF has a price to earnings ratio (PE ratio) of 5.68.

No news to show yet.

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	SP
4	0	0	0	0	0	0	0	SP
12	0	0	0	0	0	0	0	SP
26	0	0	0	0	0	0	0	SP
52	0	0	0	0	0	0	0	SP
156	0	0	0	0	0	0	0	SP
260	0	0	0	0	0	0	0	SP

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
TRAWTraws Pharma Inc	US$ 15.57 (210.16%)	14.63M
RELIReliance Global Group Inc	US$ 3.34 (178.33%)	59.12M
RAPTRAPT Therapeutics Inc	US$ 1.97 (138.67%)	79.14M
DRCTDirect Digital Holdings Inc	US$ 1.01 (83.64%)	2.17M
RUMRumble Inc	US$ 12.18 (69.40%)	18.12M
AILEiLearningEngines Inc	US$ 0.3277 (-62.97%)	5.3M
MGOLMGO Global Inc	US$ 0.3879 (-59.17%)	3.65M
XBITXBiotech Inc	US$ 3.57 (-44.04%)	55.87k
PBMPsyence Biomedical Ltd	US$ 2.1686 (-31.81%)	858.45k
NVNINVNI Group Ltd	US$ 6.35 (-25.99%)	1.8M
EDBLEdible Garden AG Inc	US$ 0.388188 (63.31%)	107.64M
RGTIRigetti Computing Inc	US$ 11.29 (20.49%)	86.77M
RAPTRAPT Therapeutics Inc	US$ 1.9004 (130.24%)	79.38M
RELIReliance Global Group Inc	US$ 3.327 (177.25%)	59.13M
RIMEAlgorhythm Holdings Inc	US$ 0.084499 (10.60%)	56.24M

Explosivo

Explosivo 4分前

The pied piper ladies and gentlemen.

Maesaeyang

Maesaeyang 4分前

sill in progress

jay_tee

jay_tee 4分前

I hope those who are dumping at .0001 just to get out and break even minus commission, wake up to billion share traded days with .0006 or more on the bid. Happens all the time all of a sudden....

poster44ny

poster44ny 4分前

$MAJOR-HHSE-NEWS:..Best-Selling Author Barr-McClellan Reveals-Campaign-Insights and Strategies for Trump Victory in 2024 Election

https://www.einpresswire.com/article/771257686/best-selling-author-barr-mcclellan-reveals-campaign-insights-and-strategies-for-trump-victory-in-2024-electi

Pnypnchr

Pnypnchr 4分前

I'm happy with a loss if need be. Call me everything in the book, that seems to be your forte.

Btw "grow up" is only said by girlies!

rayovac812

rayovac812 4分前

Approval will be a slam dunk @ the EMA, and I think within 2025. Now that the weaker thinkers are catching up, and shorts will be forced to accept the reality that Blarcamesine will have a better than 83% chance of approval, the landscape is going to change.

No chance submission wa

rayovac812

rayovac812 4分前

Approval will be a slam dunk @ the EMA, and I think within 2025. Now that the weaker thinkers are catching up, and shorts will be forced to accept the reality that Blarcamesine will have a better than 83% chance of approval, the landscape is going to change.

No chance submission wa

floridaboy

floridaboy 5分前

What ia a relief defendent?

KILLAZILLA

KILLAZILLA 5分前

LOLOLOLOL....."OFFICIAL PR'S"

PATENT SEARCH COMES UP WITH NOTHING!!!

you STILL HAVEN'T PROVIDED ANY PROOF!!!

TucsonPhil

TucsonPhil 5分前

Or, the company has no plan, and is just issuing shares to keep paying employees and management.

hweb2

Congrats on still having BKTI to sell up here. What a run! Yeah I agree why hold into the next earnings report with the seasonality. Next 2 quarters will be weaker. Still should be favorable comps. But after this incredible run, it seems the risk is to the downside.

p.s. wade m

attilathehunt

attilathehunt 6分前

YEP...Gilead paid 12B for KITE in 2017....that's about 15B in todays dollars...Given the better safety and effectiveness, we are worth north of $15B upon approval...let alone deals and other cancers!!

Any day now!!

weedtrader420

weedtrader420 6分前

No worries Santa Claus always comes to town, he’s making a list and he’s checking it twice✅✅

marcis

Yes I’m gifting $RDAR my first OTC to feel strong enough to gift 🎁 with its value so enormously above this current share price

Happy Holidays

misterfishman

misterfishman 6分前

roller coaster ride up and down, stay on the ride peeps ride not over yet, next year will be our exit .......maybe LOL.

PinkPennies

PinkPennies 6分前

LAES $4.31 hod .. what a beautiful move!

found_it2

found_it2 6分前

Finally! The west coast is just waking up to this news!

fwb

Happy FESTIVUS (for the rest of us)

tw0122

$17.89 halt tiny resistance at $17.96 then $20 then it's up to $27 blow Santa up

Fuse78

Ah that's right, this company is a supposed dead beat publisher too... lol
I forgot since they haven't done squat with that either in over a decade...
Ride that trump hype it might get a decent pump...
Need like 10-20 mill a day though...
You guys don't have enough ammo t

Batman412

Batman412 7分前

Whoever is getting 1s is a lucky dog

somberfox

somberfox 7分前

We will see results in 3-5 holidays.

coccyx

Social Media Links for M2Bio and their LOB's

A lot of things hitting on social media.

M2bio:
M2Bio Sciences:
- Instagram: (https://instagram.com/m2bio.sciences/)
- Facebook: (https://facebook.com/M2BioSciences)
- Twitter:
(https

Slojab

You're counting down to the days before the corporate update. Expecting something good? Nothing came of the last one.

Fidelity US Value ETF

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約